Related Experiment Video
Updated: Mar 26, 2026

Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
Published on: May 31, 2018
Substance P enhances tissue factor release from granulocyte-macrophage colony-stimulating factor-dependent
Rui Yamaguchi1, Takatoshi Yamamoto2, Arisa Sakamoto2
1Graduate School of Medical Science, Kumamoto Health Science University, Kumamoto, Japan; Graduate School of Medical Science, Kumamoto University Medical School, Kumamoto, Japan.
Abstract:
Granulocyte-macrophage colony stimulating factor (GM-CSF) induces procoagulant activity of macrophages. Tissue factor (TF) is a membrane-bound glycoprotein and substance P (SP) is a pro-inflammatory neuropeptide involved in the formation of membrane blebs. This study investigated the role of SP in TF release by GM-CSF-dependent macrophages. SP significantly decreased TF levels in whole-cell lysates of GM-CSF-dependent macrophages. TF was detected in the culture supernatant by enzyme-linked immunosorbent assay after stimulation of macrophages by SP. Aprepitant (an SP/neurokinin 1 receptor antagonist) reduced TF release from macrophages stimulated with SP. Pretreatment of macrophages with a radical scavenger(pyrrolidinedithiocarbamate) also limited the decrease of TF in whole-cell lysates after stimulation with SP. A protein kinase C inhibitor (rottlerin) partially blocked this macrophage response to SP, while it was significantly inhibited by a ROCK inhibitor (Y-27632) or a dynamin inhibitor (dinasore). An Akt inhibitor (perifosine) also partially blocked this response. Furthermore, siRNA targeting p22phox, β-arrestin 2, or Rho A, blunted the release of TF from macrophages stimulated with SP. In other experiments, visceral adipocytes derived from cryopreserved preadipocytes were found to produce SP. In conclusion, SP enhances the release of TF from macrophages via the p22phox/β-arrestin 2/Rho A signaling pathway.
Insights
Substance P (SP) enhances tissue factor (TF) release from macrophages, a key process in blood clotting. This release is mediated by the p22phox/β-arrestin 2/Rho A signaling pathway.
Area of Science:
- Immunology
- Cell Biology
- Biochemistry
Background:
- Granulocyte-macrophage colony-stimulating factor (GM-CSF) stimulates procoagulant activity in macrophages.
- Tissue factor (TF) is crucial for coagulation, and substance P (SP) is a pro-inflammatory neuropeptide involved in membrane bleb formation.
Purpose of the Study:
- To investigate the role of substance P (SP) in regulating tissue factor (TF) release from GM-CSF-dependent macrophages.
- To elucidate the signaling pathways involved in SP-mediated TF release.
Main Methods:
- Enzyme-linked immunosorbent assay (ELISA) to quantify TF in cell lysates and supernatants.
- Pharmacological inhibition of SP receptors, radical scavengers, and signaling pathway components (PKC, ROCK, dynamin, Akt).
- Gene silencing using siRNA targeting p22phox, β-arrestin 2, and Rho A.
Main Results:
- SP significantly decreased intracellular TF levels but increased TF in the culture supernatant of macrophages.
- Aprepitant (SP/neurokinin 1 receptor antagonist) and pyrrolidinedithiocarbamate (radical scavenger) reduced SP-induced TF release.
- Inhibitors of ROCK (Y-27632) and dynamin (dinasore), as well as siRNA targeting p22phox, β-arrestin 2, or Rho A, significantly blunted TF release.
Conclusions:
- Substance P promotes the release of tissue factor from macrophages.
- This process is regulated by the p22phox/β-arrestin 2/Rho A signaling pathway.
- Visceral adipocytes were identified as a source of SP.
Related Concept Videos
Differentiation of Common Myeloid Progenitor Cells
Regulation of Hematopoietic Stem Cells
Amplifying Signals via Enzymatic Cascade
IP3/DAG Signaling Pathway
Intracellular Signaling Affects Focal Adhesions
Some...

